Sign in
4

Changes in Ownership

Veradermics, Inc Filed Acc 0001628280-26-057813

Chief Executive Officer sold 67,500 shares at an average $107.86 ($7,280,713)

  • Chief Executive Officer acquired 3,452 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Waldman Reid Alexander · Chief Executive Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-17 Exercise or conversion : show line 1 in the form 10b5-1 +3,452 $12.19 $42,080 238,324 D
2026-08-17 Sale : show line 2 in the form 10b5-1 −11,527 $106.72 $1,230,161 226,797 D
2026-08-17 Sale : show line 3 in the form 10b5-1 −25,234 $107.53 $2,713,412 201,563 D
2026-08-17 Sale : show line 4 in the form 10b5-1 −27,490 $108.45 $2,981,291 174,073 D
2026-08-17 Sale : show line 5 in the form 10b5-1 −3,000 $109.38 $328,140 171,073 D
2026-08-17 Sale : show line 6 in the form 10b5-1 −249 $111.28 $27,709 170,824 D
Open-market sales · 67,500 sh · avg $107.86 · $7,280,713

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-17 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −3,452 0 D
Loading xslF345X06/wk-form4_1787101490.xml…